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Lavender is traditionally alleged to have a variety of therapeutic and curative properties, ranging from inducing relaxation to treating
parasitic infections, burns, insect bites, and spasm. There is growing evidence suggesting that lavender oil may be an effective
medicament in treatment of several neurological disorders. Several animal and human investigations suggest anxiolytic, mood
stabilizer, sedative, analgesic, and anticonvulsive and neuroprotective properties for lavender.These studies raised the possibility of
revival of lavender therapeutic efficacy in neurological disorders. In this paper, a survey on current experimental and clinical state
of knowledge about the effect of lavender on the nervous system is given.
1. Introduction
The genus Lavandula is native to the lands surrounding the
Mediterranean Sea and southern Europe through northern
and easternAfrica andMiddle Eastern countries to southwest
Asia and southeast India. It includes more than 30 species,
dozens of subspecies, and hundreds of hybrids and selected
cultivars.
The different varieties of this plant range in height from
9 inches to 3 feet, although some may grow taller with
age. Lavender are divided into four main categories: L.
angustifolia, commonly known as English Lavender, is a
frost hardy species that has many pretty cultivars, habit, and
blossom color (formerly known as L. vera or L. officinalis);
L. stoechas is a large plant with greenish-grey foliage and
late blooming with a very strong odor (sometimes known
as French lavender); L. latifolia, a Mediterranean grass-like
lavender; andL. intermedia, which is a sterile cross between L.
latifolia andL. angustifolia.The various lavenders have similar
ethnobotanical properties and major chemical constituents
[1].
The main constituents of lavender are linalool, linalyl
acetate, 1,8-cineole B-ocimene, terpinen-4-ol, and camphor.
However, the relative level of each of these constituents
varies in different species [1, 2]. Lavender oil, obtained
from the flowers of Lavandula angustifolia (Family: Lami-
aceae) by steam distillation, is chiefly composed of linalyl
acetate (3,7-dimethyl-1,6-octadien-3yl acetate), linalool (3,7-
dimethylocta-1,6-dien-3-ol), lavandulol, 1,8-cineole, lavan-
dulyl acetate, and camphor. Whole lavender oil and its
major components linalool and linalyl acetate are used in
aromatherapy. The major components of lavender oil were
identified as 51% linalyl acetate and 35% linalool measured by
gas chromatography and gas chromatography-linked Fourier
Transform Infrared analysis [1–3].
Most commonly lavender is recommended for oral
administration. However, it is also being employed in aro-
matherapy (inhalation of lavender; [4, 5]), aromatherapy
massage, dripping oil [6], and bathing [7]. Unlike many
other essential oils used in aromatherapy, lavender oil is
often applied undiluted to the skin. The study of Jager et
al. [8] suggested that essential oils and their components
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are rapidly absorbed through the skin. Linalool and linalyl
acetate were shown to be rapidly detected in plasma after
topical application with massage, reaching peak levels after
approximately 19min [8]. At least since medieval periods,
lavender has been a source of drugs as well as perfumes,
soaps, flavorings, and crafts. Lavender has a long history of
medicinal use and is suggested to possess anticonvulsant,
antidepressive, anxiolytic, sedative, and calming properties
[1, 9–12]. Lavender also prescribed by some medieval physi-
cians such as Ebn-e-sina and Razi for treatment of epilepsy
and migraine attacks. Furthermore, lavender is considered
beneficial in treatment of pain and tremor [9–12].
In recent years, several animal and human investigations
have indeed evaluated traditional medical remedies of laven-
der using modern scientific methods. These studies raised
the possibility of revival of lavender therapeutic efficacy
in neurological disorders on the basis of evidence-based
medicine [12, 13].
2. Animal Studies
Several animal experiments suggest anxiolytic, sedative, anal-
gesic, and anticonvulsive and neuroprotective properties for
lavender [14]. It was shown that lavender possesses an anti-
conflict effect in mice [15]. Continuous exposures to lavender
essential oils for 7 days significantly inhibited anxiety- and
depression-like behaviors tested by elevated plus-maze and
forced swimming tests in rats [16]. Lavender oil produced
significant antianxiety effects in the Geller conflict and the
Vogel conflict tests in mice. Linalool, a major constituent of
lavender oil, produced significant anticonflict effects in the
Geller and Vogel tests; findings that were similar to those of
lavender oil [17]. Effects of lavender oil were compared with
chlordiazepoxide, as a reference anxiolytic, on open-field
behavior in rats. Lavender oil exhibited antianxiety properties
similar to those of chlordiazepoxide [18]. Anxiolytic effect of
lavender was also compared with diazepam in elevated plus-
maze test in theMongolian gerbil. Exposure to lavender odor
showed an anxiolytic profile similar to diazepam in female
gerbils [19]. Investigation of the effects of inhaled linalool on
anxiety, aggressiveness, and social interaction inmice showed
anxiolytic properties in the light/dark test, increased social
interaction, and decreased aggressive behavior [20].
Local anesthetic effect of lavender and its constituents
(linalool and linalyl acetate) is reported in both in vivo and
in vitro animal experiments [21]. In the rabbit conjunctival
reflex test, treatment with a solution of lavender essential
oil as well as with linalyl acetate or linalool induced a
dose-dependent enhancement in the number of stimuli
necessary to provoke the reflex [21]. The methanolic extract
of lavender (200–600mg/kg) dose-dependently produced
sedative effects in mice. This was indicated by the relatively
longer time for the reestablishment and number of head dips
during the traction and hole-board tests [22]. To evaluate
the sedative effects of lavender, the immobility of overag-
itated mice induced by caffeine was ascertained after the
inhalation of lavender. Lavender odor significantly increased
the immobile state in mice treated with caffeine [23]. Expo-
sure of mice to lavender odor in a dark cage resulted in
depression of motor activity, whilst the plasma levels of
linalool rose in proportion to the length of exposure [24].The
intraplantar injection of capsaicin produced an intense and
short-lived licking/biting response in mice. The capsaicin-
induced nociceptive response was reduced significantly by
intraplantar injection of lavender and linalool [25]. Either
oral administration or inhalation of lavender essential oil
significantly reduced the chemical and thermal pain without
evidence of central adverse effects in adult mice. Opioidergic
neurotransmission seems to be involved in lavender-induced
analgesia since only naloxone pretreatment prevents its effect
in writhing test. Cholinergic neurotransmitter system also
appears to play a role in lavender analgesia. The blockade
of muscarinic and nicotinic receptors prevented analgesic
effects of lavender [26].
Exposure to lavender effectively improved spatial mem-
ory deficits induced by dysfunction of the cholinergic sys-
tem [27]. Administration of lavender in animal model of
Alzheimer’s disease (rat model established by intracere-
broventricular injection of A𝛽1) effectively reversed spa-
tial learning deficits [28]. Repeated application of laven-
der in mice demonstrated a more rapid sleep onset with
longer duration of sleep [29]. Anticonvulsant effect for
hydroalcoholic extract of lavender was reported against
chemoconvulsant-induced seizures in male mice. Lavender
inhibited the onset, shortened the duration, and reduced the
intensity of seizure attacks [30]. Anticonvulsant effects of
lavender together with diminution in spontaneous activity,
when combined with other narcotics, have been reported
[31, 32]. Inhalation of lavender was also noted to inhibit
convulsion induced by pentylenetetrazol, nicotine, or elec-
troshock inmice [33]. Linalool, one of themajor components
of lavender oil, has been shown to inhibit the convulsion
induced by pentylenetetrazol and transcorneal electroshock
in different animal models [34, 35], an effect that may
induce via a direct interaction with the glutamatergic NMDA
subreceptor as well as GABAA receptors [36]. The neuropro-
tective effect of lavender oil on cerebral ischemia/reperfusion
injury was investigated in mice. Focal cerebral ischemia was
induced by the intraluminal occlusion. An aqueous extract
of lavender has been shown to diminish glutamate-induced
neurotoxicity in rat pups cerebellar granular cell culture
[37]. Lavender oil significantly decreased neurological deficit
scores, infarct size, and the levels of mitochondria-generated
reactive oxygen species and attenuated neuronal damage in
focal cerebral ischemia induced by the intraluminal occlusion
in mice [38].
3. Mechanisms of Action of Lavender in
the Nervous System
Several investigations were performed to clarify the mech-
anism of action of lavender in neuronal tissues. Lavender
inhibited lipopolysaccharide-induced inflammatory reaction
in human monocyte THP-1 cells effect, which might be
associated with the expression of HSP70 [39]. Antioxidant
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and relatively weak cholinergic inhibition was reported for
lavender [38, 40] and linalool [41–43]. Linalool inhibited
acetylcholine release and alters ion channel function at the
neuromuscular junction [44]. These findings indicate that
several targets relevant to treatment of Alzheimer’s disease;
anticholinergic, neuroprotective, and antioxidant activities
could be found in lavender. The neuroprotective effect of
lavender oil against cerebral ischemia/reperfusion injury is
suggested to be attributed to its antioxidant effects [38].
Evaluation of the effects of lavender oil on motor activity and
its relationship to dopaminergic neurotransmission revealed
that intraperitoneal application of lavender significantly
increased rotarod activity and enhanced dopamine receptors
subtype D
3
in the olfactory bulbs of mice [45]. Lavender oil
is also suggested tomodulate GABAergic neurotransmission,
especially on GABAA receptors, and enhance inhibitory tone
of the nervous system [29, 36, 46]. Cholinergic system is
suggested to play a role in lavender analgesic, antianxiety,
antidepression, and anticonvulsant effects of lavender [16, 26,
33].
Fos is a nuclear transcription factor protein encoded by
an immediate early gene c-fos, and it is an early marker
of neuronal activation. It serves as a transcriptional factor
controlling the expression of genes expected to be involved
in effective adaptation to certain situations. Lavender oil
reduced c-fos expression in paraventricular nucleus of
the hypothalamus and dorsomedial hypothalamic nucleus
[18]. Lavender oil inhibited dose-dependently the histamine
release and anti-DNP IgE-induced tumor necrosis factor-
alpha secretion from peritoneal mast cells in mice [47]. It
has been shown that lavender oil inhibited the sympathetic
nerves innervating the white and brown adipose tissues and
adrenal gland and excites the parasympathetic gastric nerve
[48, 49]. Odor of lavender oil, and especially its compo-
nent linalool, affects autonomic nerves probably through
a histaminergic response, decreases lipolysis and heat pro-
duction (energy consumption), and increases appetite and
body weight in rats [50]. Lavender may inhibit the sympa-
thetic nerve activity and lipolysis through activation of H
3
-
receptors. The hypothalamic suprachiasmatic nucleus and
histamine neurons are involved in the lipolytic responses
to the lavender oil, and tyrosine phosphorylation of BIT
(a brain immunoglobulin-like molecule with tyrosine-based
activation motifs, a member of the signal-regulator protein
family) is implicated in the relevant signaling pathways [50].
4. Human Studies
Although there is considerable debate about whether laven-
der species have a significant clinical potential either alone
or as additives to other substances, many human studies
support its effectiveness in different neurological and psycho-
logical disorders. Lavender was used predominantly in oral
administration, aromatherapy, or massage in several clinical
studies, and many benefits were claimed for use in such a
manner. In addition to psychological effects, aromatherapy
is thought to be therapeutically effective due to physiological
effects of the inhaled volatile compounds. It is believed that
inhaled lavender act via the limbic system, particularly the
amygdala and hippocampus [1]. Linalool and linalyl acetate
are rapidly absorbed through the skin after topical application
with massage and are thought to be able to cause central
nervous system depression [8].
4.1. Anxiety, Depression, and Lavender. Lavender was used
in the treatment of anxiety disorders and related conditions.
Three clinical trials were identified which investigated the
efficacy of oral lavender oil preparation (silexan; an essential
oil produced from lavender flowers by steam distillation),
administered once daily at a dose of 80mg/day, in subsyn-
dromal (mixed) anxiety disorder and generalized anxiety
disorder as well as in restlessness and agitation. Anxiolytic
effect of lavender was superior to placebo in 221 patients suf-
fering from anxiety disorder. In addition, lavender improved
associated symptoms such as restlessness, disturbed sleep,
and somatic complaints and had a beneficial influence on
general well-being and quality of life [51, 52]. In line with
this study, the efficacy of a 6-week-intake of oral lavender
oil preparation (Silexan, 80mg/day), compared to lorazepam,
was investigated in adults with generalized anxiety disorder.
This study indicates that lavender effectively ameliorates
generalized anxiety comparable to 0.5mg/daily lorazepam
[53]. Alleviation of anxiety and mood improvement were
reported in thirty-six patients admitted to an intensive care
unit, who received lavender oil (diluted to 1% concentra-
tion) aromatherapy [54]. The same results were reported
for fourteen female patients who were being treated with
chronic hemodialysis [55]. A survey in a long-stay neurology
in-patient department showed increased mood scores and
reduced psychological distress following aromatherapy with
lavender accompanied with tea tree and rosemary [56].
An investigation on the effect of lavender aromatherapy
(diluted to 2% concentration) on anxiety and depression
in the high risk postpartum woman showed a significant
improvement of the Edinburgh Postnatal Depression Scale
and Generalized Anxiety Disorder Scale after four consec-
utive weeks of administration of lavender [57]. Lavender
odor reduced anxiety in dental patients; however, it has
no effect on dental anxiety surrounding thoughts of future
dental visits [58, 59]. Testing visual analog scales to assess
anxiety, it is suggested that lavender is a simple, low-risk, cost-
effective intervention with the potential to improve preop-
erative anxiety [60]. Orally administered lavender capsules
contained 100 or 200𝜇L of organic Lavandula angustifolia
oil were tested on responses to anxiety-provoking film clips.
In this study, evaluation of State Trait Anxiety Inventory,
mood, positive and negative affect scale, heart rate, and
galvanic skin response as well as heart rate variation after
administration of lavender suggests that lavender has anx-
iolytic effects in humans suffering from low anxiety, but
these effects may not extend to conditions of severe anxiety
[61]. A clinical investigation points to antidepressive effect
of lavender. Adjuvant therapy of lavender tincture (1 : 5 in
50% alcohol; 60 drops/day) and imipramine (100mg/daily)
in treatment of forty-eight adult outpatients suffering from
mild-to-moderate depression led to a better and earlier
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improvement. Anticholinergic side effects of imipramine,
such as dry mouth and urinary retention, were observed less
often when lavender administered with impramine. These
results suggest that lavender is an effective adjuvant therapy
in combination with imipramine, resulting in a superior and
quicker improvement in depressive symptoms [62].
4.2. Neuroimaging and Lavender. Evaluation of brain region-
al metabolic activity with positron emission tomography
in ten healthy women after the lavender odor stimulus
demonstrated neuronal enhancement in the orbitofrontal,
posterior cingulate gyrus, brainstem, thalamus, and cerebel-
lum and reduction of activity in the pre/post-central gyrus
and frontal eye field. These findings indicate that lavender
aromatherapy in addition to relaxation effect may enhance
arousal level in some subjects [63]. Using functionalmagnetic
resonance imaging (fMRI), significant activation in major
olfactory brain structures, including the primary olfactory
cortex, entorhinal cortex, hippocampus and parahippocam-
pal cortex, thalamus, hypothalamus, orbitofrontal cortex, and
insular cortex and its extension into the inferior lateral frontal
region was reported in nineteen healthy participants after
application of 10% lavender diluted in dipropylene glycol
[64]. Cortical perfusion increment after sensorial stimulation
with lavender was evaluated by single photon emission
computed tomography in ten healthy adults. A significant
activation was observed in gyrus rectus, orbitofrontal cortex,
and superior temporal cortical areas. A slight perfusion
increase also existed inmiddle temporal and parieto-occipital
regions [65]. Lavender odor was delivered via the orthonasal
(odor perceived through the nose) and retronasal (odor
perceived through the mouth) routes and brain response
was measured with fMRI in 20 subjects. In addition to
the activation at the base of the central sulcus by lavender,
retronasal stimulationwith odor resulted in a significant peak
in the ventral insula compare to orthonasal application. In
contrast, orthonasal application yielded a peak in the right
caudate nucleus that approached significance in comparison
to retronasal way [66].
4.3. Electroencephalography (EEG) and Lavender. It has been
suggested that some neurological disorders with significant
EEG changes, such as epilepsy, may be benefited by aro-
matherapy [10, 11]. Lavender affects human EEG pattern
accompanied with its anxiolytic effect. It is reported that
inhalation of lavender (diluted to 10% concentration) for 3
minutes increases alpha power of EEG as decreases anxiety
and brings the subject to a better mood in 40 healthy adults
[67]. Increases in theta (4–8Hz) and alpha (8–13Hz) wave
activity may cause a range of general relaxation effects and
can be induced by chemical and nonchemical techniques
[68]. It has been shown that during inhalation with lavender
(diluted to 10% concentration) in 20 participants, the power
of theta and alpha wave activities were significantly increased
in all brain regions. This study found relaxing effects with
increases of alpha wave activities after administering laven-
der; indicating the EEG evidence of relaxation by lavender
aromatherapy [69]. Furthermore, lavender aromatherapy is
reported to produces EEG patterns characteristics of subjects’
feeling comfortable [70]. Lavender oil administered in an
aroma stream shows modest efficacy in the treatment of
agitated behavior in patients with severe dementia [71].
Resting frontal EEG asymmetry is suggested to be a
predictor of symptom change and end-state functioning in
patients with social anxiety disorder who undergo efficacious
psychological treatment [72]. Evaluation of frontal EEG
asymmetry shifting in thirty-nine adult participants and
twenty-seven full-term newborns revealed greater relative
left frontal EEG activation (associated with greater approach
behavior and less depressed affect) after aromatherapy with
lavender. Further studies in these volunteers indicate that
lavender may induce left frontal EEG shifting in adults and
infants, who show greater baselines relative to right frontal
EEG activation. It is suggested that both infants and adults
with greater relative right frontal EEG activation at baseline
may be more affected by lavender application [73].
4.4. Sleep and Lavender. Lavender has been suggested as an
excellent natural remedy to treat insomnia and improve the
sleep quality. Single-blind randomized studies investigated
the effectiveness of lavender odor on quality of sleep showed
that lavender improved the mean scores of sleep quality in
fifteen healthy students [74], in sixty-four ischemic heart
disease patients [75], and in thirty-four midlife women with
insomnia [76]. Ten individuals with insomnia, verified by a
score of 5 or more on the Pittsburgh Sleep Quality Index
(PSQI), were treated with lavender odor. Six to eight drops of
lavender oil added each night to the cartridge improved the
PSQI score by −2.5 points. More notable improvements were
seen in females and younger participants. Milder insomnia
also improved more than severe ones [77]. Oral lavender oil
preparation (80mg/day) showed a significant beneficial influ-
ence on quality and duration of sleep and improved general
mental and physical health without causing any unwanted
sedative or other drug specific effects in 221 patients suffering
from subsyndromal (mixed) anxiety disorder [52]. Amixture
of essential oils including lavender, basil, juniper, and sweet
marjoram is shown to reduce sleep disturbance and improve
overall well-being in older patients [78]. In a clinical study
on four benzodiazepine dependent geriatric patients, there
was a significant decrease in sleep duration by stopping
benzodiazepine treatment, which was restored to previous
levels by substitution of aromatherapy with lavender oil.
This study suggested that ambient lavender oil might be
used as a temporary relief from continued medication for
insomnia and reduces the side-effects of these drugs [79]. In
a study on thirty-one hospitalized patients, administration of
lavender odor showed a trend towards an improved quality
of daytime wakefulness and more sustained sleep at night
[80]. In contrary to these data, it should be noted that the use
of aromatherapy massage with lavender oil has no beneficial
effect on the sleep patterns of children with autism attending
a residential school. It was suggested that this therapy may
show greater effects in the home environment or with longer-
term interventions [81].
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4.5. Pain and Lavender. Lavender reported to be useful in the
treatment of acute as well as chronic or intractable pain [82].
It has been shown that foot massage using lavender essential
oil in 100 ICU patients of whom 50% were receiving artificial
ventilation was effective in lowering blood pressure, heart
rate, respiratory rate, wakefulness, and pain [83]. Treatment
of recurrent aphthous ulceration with lavender oil in 115
patients revealed a significant pain relief mostly from the first
dose, ulcer size reduction, increased rate of mucosal repair,
and healing within three days of treatment compared to
baseline and placebo groups [84]. Stress level, the bispectral
index (a promising parameter for monitoring sedation), and
pain intensity of needle insertion were significantly reduced
after receiving oxygen with a face mask coated with lavender
oil for five minutes compared with the control in thirty
volunteers [85]. Aromatic oil massage with essential oils
blended with lavender, clary sage, and marjoram in a 2 : 1 : 1
ratio in forty-eight outpatients with primary dysmenorrhea
alleviated the pain and reduced the duration of dysmenorrhea
[86]. Aromatherapy by using lavender essence was also
reported as a successful and safe complementary therapy
in reduction of pain after the cesarean section in 200 term
pregnant women [87] and after episiotomy in 60 primiparous
women [88] as well as in perineal discomfort following
normal childbirth in 635 women [89, 90]. It has been
shown that lavender aromatherapy through an oxygen face
mask with two drops of 2% lavender oil can be used to
reduce the demand for opioids in twenty-five patients after
immediate postoperative period of breast biopsy surgery [91]
and for other analgesics in fifty-four patients undergoing
laparoscopic adjustable gastric banding [92]. In contrast to
these observations, the aroma of essential oil of lavender ease
anxiety but not perception of pain during elective cosmetic
facial injections of botulinum toxin for the correction of
glabellar wrinkle [93]. A course of eight-session manual
acupressure with lavender oil (3% lavender oil; used as the
massage lubricant) over a three-week period in patients
with nonspecific subacute neck pain (32 patients) or low
back pain (61 patients) significantly alleviated the neck and
back pain and improved movements of the cervical and
lumbar spine [94, 95]. Inhalation of lavender essential oil
is suggested to be an effective and safe treatment modality
in acute management of migraine headaches. Forty-seven
patients suffering from migraine attacks reported significant
reduction of pain severity and associated symptoms after
fifteen minutes inhalation of lavender oil (2-3 drops of the
lavender essential oil rubbed onto their upper lip) in the
early stages of the attacks [5]. Aromatherapy massage with
lavender accompanied with rose geranium, rose, and jasmine
in almond and primrose oils once a week for 8 weeks is
reported as an effective treatment of menopausal symptoms
such as hot flushes, depression, and pain in climacteric
women [96].
4.6. Cognition and Lavender. The use of aromas to modulate
affect and mood has been reported by several ancient and
medieval physicians [9–12]. The positive effects of different
medicinal plants as cognition enhancers have been reported
[97]. To assess the olfactory impact of the essential oils of
lavender on cognitive performance and mood in healthy
volunteers, the Cognitive Drug Research computerized cog-
nitive assessment battery was performed in 144 participants.
Analysis of performance revealed that lavender odor (four
drops of oil were applied to a diffuser pad) produced a
significant decrement in performance of working memory
as well as impaired reaction times for both memory and
attention. In addition, a significant effect was found for
lavender compared to controls for degree of contentedness,
indicating that lavender is capable of elevating mood, or at
least maintaining good mood during the completion of a
challenging test battery under laboratory conditions [98].
There is an improvement of emotional state in the work
environment following the use of the lavender oil burners.
Using lavender oil in burners for a 3-month period, nearly
90% of respondents (a total of 66 subjects) believed that there
had been an improvement in thework environment following
the use of lavender oil [99]. Aromatherapy consisted of the
use of rosemary and lemon essential oils in the morning,
and lavender and orange in the evening showed significant
improvement in personal orientation related to cognitive
function in 28 elderly patients suffering from different forms
of dementia [100]. It has been shown that unconscious
perception of lavender odor can significantly affect the rate
of errors made in the mathematical and letter counting tests.
In the presence of the odor of lavender, 108 subjects made
fewer errors than in the presence of no odor or the odor of
jasmine [101]. By comparison, it has been reported lavender
to impair arithmetic reasoning, but not memory, when
compared to cloves, with no concomitant effect on mood for
either odor [102]. Application of oral lavender (80mg/day) for
sixweeks in fifty patients suffering fromneurasthenia or post-
traumatic stress disorder showed significant improvements of
their general mental health status and quality of life [103].
5. Safety
Although sufficient evidence exists to recommend lavender
for short-term treatment of some neurological disorders,
long-term trials and observational studies are needed to
establish the safety of long-term use as well as overall efficacy
in the context of treatment andmanagement of these diseases.
The available data suggests that short-term therapy with
lavender is relatively safe. However, there are some reports
of adverse effects after application of lavender. Gynecomastia
coincided with the topical application of products, which
contained lavender and tea tree oils was reported in three
boys aged between 7 to 10 years. Gynecomastia resolved in all
patients shortly after discontinuation of products containing
these oils. Furthermore, studies in human cell lines indicated
that the lavender oil had estrogenic and antiandrogenic
activities [104]. Lavender should be also used cautiously or
avoided in patients with known allergy to lavender [105,
106]. In the oral lavender trials, Kasper et al. [52] reported
slightly more adverse events in the lavender group than
the placebo group; the most frequently reported adverse
effects were related to infections and infestations, followed
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by gastrointestinal disorders and nervous system disorders.
Woelk and Schläfke [107] reported slightly more adverse
events in the lavender group than the lorazepam group
but again none were described as serious. Gastrointestinal
adverse events, such as nausea and dyspepsia, after receiving
silexan were reported [107]. Ingestion should be avoided
during pregnancy (due to emmenagogue effects) [108] and
breastfeeding. Lavender oil has no potential for drug abuse
[109].
6. Critical Overview and Conclusion
A recent increase in the popularity of alternative medicine
and natural products has renewed interest in lavender and
their essential oils as potential natural remedies [2]. This
review may be useful to increase our knowledge of lavender
pharmacological effects and improve our future experimen-
tal and clinical research plans. Although it is shown that
lavender may have a significant clinical potential either in
their own right or as adjuvant therapy in different disor-
ders, however, due to some issues, such as methodological
inadequacies, small sample sizes, short duration of lavender
application, lack of information regarding dose rationale,
variation between efficacy and effectiveness trials, variability
of administration methods, the absence of a placebo com-
parator, or lack of control groups more standard experiments
and researches are needed to confirm the beneficial effect of
lavender in the neurological disorders [109]. Methodological
and oil identification problems have also hampered the
evaluation of the therapeutic significance of some of the
research on lavender. The dried lavender flowers used in
some trials were sourced from a local herb store (i.e., [62]).
Although taxonomic identification was confirmed in these
studies, without quantification of key constituents the quality
of the herbal product may be questionable [110]. Although
some studies defined the contents of lavender, it is essential
that all future clinical studies specify the exact derivation of
the oils used in the study and, preferably, include a profile
of the liquid or the percentage composition of the major
constituents. In addition, several factors, such as temperature,
skin type and quality, and the size of area being treated,
which may affect the level and rate of lavender absorption
aftermassage or aromatherapy, were not considered in several
investigations. Many discreet compounds in lavender oil
have shown a myriad of potential therapeutic effects, and
researchers continue to seek novel treatments to different
ailments [2].
Only few clinical investigations on lavender are available
using diverse administration methods (i.e., oral, aromather-
apy, and as a massage oil). The evidence for oral lavender is
promising; however, until independent studies emerge with
long-term follow-up data, it remains inconclusive [109]. The
use of more widely used forms of lavender administrations
(aromatherapy, inhalation, massage, etc.) is not currently
supported by good evidence of efficacy. Future clinical trials,
well-reported and adopting rigorous standard methodology,
in combination with experimental pharmacological research,
would help to clarify the therapeutic value of lavender for
neurological and psychological disorders [109, 110].
The apparently low reporting of adverse reactions could
imply tolerability and safety [110]. However, most studies
failed to provide details which may have masked these and
the studies only involved small numbers of participants.
It is crucial to get good tolerability and safety data for
all modes of lavender application. Thus longer-term follow
ups would be required especially for oral lavender before
it is recommended for treatment of neurological and/or
psychological disorders.
Authors’ Contribution
P. H. Koulivand andM. K. Ghadiri contributed equally to this
paper.
Acknowledgments
The authors acknowledge support by Deutsche Forschungs-
gemeinschaft and Open Access Publication Fund of Univer-
sity of Muenster.
References
[1] H. M. A. Cavanagh and J. M. Wilkinson, “Biological activities
of lavender essential oil,” Phytotherapy Research, vol. 16, no. 4,
pp. 301–308, 2002.
[2] G. Woronuk, Z. Demissie, M. Rheault, and S. Mahmoud,
“Biosynthesis and therapeutic properties of lavandula essential
oil constituents,” Planta Medica, vol. 77, no. 1, pp. 7–15, 2011.
[3] A. Prashar, I. C. Locke, and C. S. Evans, “Cytotoxicity of
lavender oil and its major components to human skin cells,”Cell
Proliferation, vol. 37, no. 3, pp. 221–229, 2004.
[4] W. N. Setzer, “Essential oils and anxiolytic aromatherapy,”
Natural Product Communications, vol. 4, no. 9, pp. 1305–1316,
2009.
[5] P. Sasannejad, M. Saeedi, A. Shoeibi et al., “Lavender essential
oil in the treatment of migraine headache: a placebo-controlled
clinical trial,” European Journal of Neurology, vol. 67, no. 5, pp.
288–291, 2012.
[6] F. Xu, K. Uebaba, H. Ogawa et al., “Pharmaco-physio-
psychologic effect of ayurvedic oil-dripping treatment using an
essential oil from Lavendula angustifolia,” Journal of Alternative
and Complementary Medicine, vol. 14, no. 8, pp. 947–956, 2008.
[7] N. Morris, “The effects of lavender (Lavendula angustifolium)
baths on psychological well-being: two exploratory randomized
controls trials,” Complementary Therapies in Medicine, vol. 10,
no. 4, pp. 223–228, 2002.
[8] W. Jager, G. Buchbauer, L. Jirovetz, and M. Fritzer, “Percuta-
neous absorbtion of lavender oil from a massage oil,” Journal
of the Society of Cosmetic Chemists, vol. 43, pp. 49–54, 1992.
[9] N. Vakili and A. Gorji, “Psychiatry and psychology in medieval
Persia,” Journal of Clinical Psychiatry, vol. 67, no. 12, pp. 1862–
1869, 2006.
[10] A. Gorji and M. Khaleghi Ghadiri, “History of epilepsy in
Medieval Iranian medicine,” Neuroscience and Biobehavioral
Reviews, vol. 25, no. 5, pp. 455–461, 2001.
Evidence-Based Complementary and Alternative Medicine 7
[11] A. Gorji and M. K. Ghadiri, “History of headache in medieval
Persian medicine,” Lancet Neurology, vol. 1, no. 8, pp. 510–515,
2002.
[12] A. Gorji, “Pharmacological treatment of headache using tra-
ditional persian medicine,” Trends in Pharmacological Sciences,
vol. 24, no. 7, pp. 331–334, 2003.
[13] S. S. Denner, “Lavandula angustifolia miller: english lavender,”
Holistic Nursing Practice, vol. 23, no. 1, pp. 57–64, 2009.
[14] A. H. Gilani, N. Aziz, M. A. Khan et al., “Ethnopharmacological
evaluation of the anticonvulsant, sedative and antispasmodic
activities of Lavandula stoechas L,” Journal of Ethnopharmacol-
ogy, vol. 71, no. 1-2, pp. 161–167, 2000.
[15] T. Umezu, “Behavioral effects of plant-derived essential oils
in the Geller type conflict test in mice,” Japanese Journal of
Pharmacology, vol. 83, no. 2, pp. 150–153, 2000.
[16] L. Hritcu, O. Cioanca, andM. Hancianu, “Effects of lavender oil
inhalation on improving scopolamine-induced spatial memory
impairment in laboratory rats,” Phytomedicine, vol. 19, no. 6, pp.
529–534, 2012.
[17] T. Umezu, K. Nagano, H. Ito, K. Kosakai, M. Sakaniwa, and M.
Morita, “Anticonflict effects of lavender oil and identification
of its active constituents,” Pharmacology Biochemistry and
Behavior, vol. 85, no. 4, pp. 713–721, 2006.
[18] D. Shaw, J. M. Annett, B. Doherty, and J. C. Leslie, “Anxiolytic
effects of lavender oil inhalation on open-field behaviour in
rats,” Phytomedicine, vol. 14, no. 9, pp. 613–620, 2007.
[19] B. F. Bradley, N. J. Starkey, S. L. Brown, and R. W. Lea, “Anxi-
olytic effects of Lavandula angustifolia odour on theMongolian
gerbil elevated plus maze,” Journal of Ethnopharmacology, vol.
111, no. 3, pp. 517–525, 2007.
[20] V. M. Linck, A. L. da Silva, M. Figueiro´, E. B. Carama˜o, P.
R. H. Moreno, and E. Elisabetsky, “Effects of inhaled Linalool
in anxiety, social interaction and aggressive behavior in mice,”
Phytomedicine, vol. 17, no. 8-9, pp. 679–683, 2010.
[21] C. Ghelardini, N. Galeotti, G. Salvatore, and G. Mazzanti,
“Local anaesthetic activity of the essential oil of Lavandula
angustifolia,” Planta Medica, vol. 65, no. 8, pp. 700–703, 1999.
[22] R. Alnamer, K. Alaoui, H. Bouidida el et al., “Sedative and
hypnotic activities of the methanolic and aqueous extracts of
Lavandula officinalis fromMorocco,”Advances in Pharmacolog-
ical Sciences, vol. 2012, Article ID 270824, 5 pages, 2012.
[23] W. C. Lim, J. M. Seo, C. I. Lee, H. B. Pyo, and B. C. Lee, “Stim-
ulative and sedative effects of essential oils upon inhalation in
mice,” Archives of Pharmacal Research, vol. 28, no. 7, pp. 770–
774, 2005.
[24] G. Buchbauer, L. Jirovetz, W. Ja¨ger, H. Dietrich, and C. Plank,
“Aromatherapy: evidence for sedative effects of the essential oil
of lavender after inhalation,” Zeitschrift fur Naturforschung, vol.
46, no. 11-12, pp. 1067–1072, 1991.
[25] T. Sakurada, H. Kuwahata, S. Katsuyama et al., “Chapter 18
intraplantar injection of Bergamot essential oil into the mouse
hindpaw. Effects on capsaicin-induced nociceptive behaviors,”
International Review of Neurobiology, vol. 85, pp. 237–248, 2009.
[26] E. Barocelli, F. Calcina, M. Chiavarini et al., “Antinociceptive
and gastroprotective effects of inhaled and orally administered
Lavandula hybrida Reverchon ”grosso” essential oil,” Life Sci-
ences, vol. 76, no. 2, pp. 213–223, 2004.
[27] D. Hartman and J. C. Coetzee, “Two US practitioners’ experi-
ence of using essential oils for wound care,” Journal of Wound
Care, vol. 11, no. 8, pp. 317–320, 2002.
[28] M. S. Kashani, M. R. Tavirani, S. A. Talaei, and M. Salami,
“Aqueous extract of lavender (Lavandula angustifolia) improves
the spatial performance of a rat model of Alzheimer’s disease,”
Neuroscience Bulletin, vol. 27, no. 2, pp. 99–106, 2011.
[29] J. Guillmain, A. Rousseau, and P. Delaveau, “Effets neurode-
presseurs de l’huile essentielle de lavandula augustifolia Mill,”
Annales Pharmaceutiques, vol. 47, pp. 337–343, 1989.
[30] A. Arzi, M. Ahamehe, and S. Sarahroodi, “Effect of hydroal-
coholic extract of Lavandula officinalis on nicotine-induced
convulsion in mice,” Pakistan Journal of Biological Sciences, vol.
14, no. 11, pp. 634–640, 2011.
[31] M. Lis-Balchin and S. Hart, “Studies on the mode of action of
the essential oil of lavender (Lavandula angustifolia P. Miller),”
Phytotherapy Research, vol. 13, pp. 540–542, 1999.
[32] S. Atanossova-Shopova andK. S. Roussinov, “On certain central
neurolotropic effects of lavender essential oil,” Bulletin of the
Institute of Physiology, vol. 8, pp. 69–76, 1970.
[33] K. Yamada, Y. Mimaki, and Y. Sashida, “Anticonvulsive effects
of inhaling lavender oil vapour,” Biological and Pharmaceutical
Bulletin, vol. 17, no. 2, pp. 359–360, 1994.
[34] E. Elisabetsky, L. F. S. Brum, and D. O. Souza, “Anticonvulsant
properties of linalool in glutamate-related seizure models,”
Phytomedicine, vol. 6, no. 2, pp. 107–113, 1999.
[35] D. P. de Sousa, F. F. F. No´brega, C. C. M. P. Santos, and R. N. de
Almeida, “Anticonvulsant activity of the linalool enantiomers
and racemate: investigation of chiral influence,”Natural Product
Communications, vol. 5, no. 12, pp. 1847–1851, 2010.
[36] L. F. Silva Brum, E. Elisabetsky, andD. Souza, “Effects of linalool
on [3H] MK801 and [3H] muscimol binding in mouse cortical
membranes,” Phytotherapy Research, vol. 15, no. 5, pp. 422–425,
2001.
[37] M. E. Bu¨yu¨kokurog˘lu, A. Gepdiremen, A. Hacimu¨ftu¨og˘lu, and
M. Oktay, “The effects of aqueous extract of Lavandula angus-
tifolia flowers in glutamate-induced neurotoxicity of cerebellar
granular cell culture of rat pups,” Journal of Ethnopharmacology,
vol. 84, pp. 91–94, 2003.
[38] D. Wang, X. Yuan, T. Liu et al., “Neuroprotective activity
of lavender oil on transient focal cerebral ischemia in mice,”
Molecules, vol. 17, no. 8, pp. 9803–9817, 2012.
[39] M. Y. Huang, M. H. Liao, Y. K. Wang et al., “Effect of lavender
essential oil on LPS-stimulated inflammation,” American Jour-
nal of Chinese Medicine, vol. 40, no. 4, pp. 845–859, 2012.
[40] S. M. Salah and A. K. Ja¨ger, “Screening of traditionally
used Lebanese herbs for neurological activities,” Journal of
Ethnopharmacology, vol. 97, no. 1, pp. 145–149, 2005.
[41] N. S. L. Perry, P. J. Houghton, A. Theobald, P. Jenner, and
E. K. Perry, “In-vitro inhibition of human erythrocyte acetyl-
cholinesterase by Salvia lavandulaefolia essential oil and con-
stituent terpenes,” Journal of Pharmacy and Pharmacology, vol.
52, no. 7, pp. 895–902, 2000.
[42] N. S. L. Perry, C. Bollen, E. K. Perry, and C. Ballard, “Salvia
for dementia therapy: review of pharmacological activity and
pilot tolerability clinical trial,” Pharmacology Biochemistry and
Behavior, vol. 75, no. 3, pp. 651–659, 2003.
[43] S. Savelev, E. Okello, N. S. L. Perry, R. M. Wilkins, and E.
K. Perry, “Synergistic and antagonistic interactions of anti-
cholinesterase terpenoids in Salvia lavandulaefolia essential oil,”
Pharmacology Biochemistry and Behavior, vol. 75, no. 3, pp. 661–
668, 2003.
[44] L. Re, S. Barocci, S. Sonnino et al., “Linalool modifies the nico-
tinic receptor-ion channel kinetics at themouse neuromuscular
8 Evidence-Based Complementary and Alternative Medicine
junction,” Pharmacological Research, vol. 42, no. 2, pp. 177–181,
2000.
[45] Y. Kim, M. Kim, H. Kim, and K. Kim, “Effect of lavender oil
on motor function and dopamine receptor expression in the
olfactory bulb of mice,” Journal of Ethnopharmacology, vol. 125,
no. 1, pp. 31–35, 2009.
[46] H.Aoshima andK.Hamamoto, “Potentiation ofGABAA recep-
tors expressed in Xenopus oocytes by perfume and phytoncid,”
Bioscience, Biotechnology and Biochemistry, vol. 63, no. 4, pp.
743–748, 1999.
[47] H. M. Kim and S. H. Cho, “Lavender oil inhibits immediate-
type allergic reaction inmice and rats,” Journal of Pharmacy and
Pharmacology, vol. 51, no. 2, pp. 221–226, 1999.
[48] J. Shen, A. Niijima, M. Tanida, Y. Horii, K. Maeda, and K.
Nagai, “Olfactory stimulation with scent of lavender oil affects
autonomic nerves, lipolysis and appetite in rats,” Neuroscience
Letters, vol. 383, no. 1-2, pp. 188–193, 2005.
[49] M. Tanida, A. Yamatodani, A. Niijima, J. Shen, T. Todo, and
K. Nagai, “Autonomic and cardiovascular responses to scent
stimulation are altered in cry KO mice,” Neuroscience Letters,
vol. 413, no. 2, pp. 177–182, 2007.
[50] J. Shen, A. Niijima, M. Tanida, Y. Horii, T. Nakamura, and K.
Nagai, “Mechanism of changes induced in plasma glycerol by
scent stimulation with grapefruit and lavender essential oils,”
Neuroscience Letters, vol. 416, no. 3, pp. 241–246, 2007.
[51] S. Kasper, M. Gastpar, W. E. Mu¨ller et al., “Efficacy and safety
of silexan, a new, orally administered lavender oil preparation,
in subthreshold anxiety disorder—evidence from clinical trials,”
Wiener Medizinische Wochenschrift, vol. 160, no. 21-22, pp. 547–
556, 2010.
[52] S. Kasper, M. Gastpar, W. E. Mu¨ller et al., “Silexan, an orally
administered Lavandula oil preparation, is effective in the
treatment of ’subsyndromal’ anxiety disorder: a randomized,
double-blind, placebo controlled trial,” International Clinical
Psychopharmacology, vol. 25, no. 5, pp. 277–287, 2010.
[53] H. Woelk and S. Schla¨fke, “A multi-center, double-blind,
randomised study of the Lavender oil preparation Silexan in
comparison to Lorazepam for generalized anxiety disorder,”
Phytomedicine, vol. 17, no. 2, pp. 94–99, 2010.
[54] C. Dunn, J. Sleep, and D. Collett, “Sensing an improvement:
an experimental study to evaluate the use of aromatherapy,
massage and periods of rest in an intensive care unit,” Journal
of advanced nursing, vol. 21, no. 1, pp. 34–40, 1995.
[55] T. Itai, H. Amayasu, M. Kuribayashi et al., “Psychological effects
of aromatherapy on chronic hemodialysis patients,” Psychiatry
and Clinical Neurosciences, vol. 54, no. 4, pp. 393–397, 2000.
[56] E.Walsh andC.Wilson, “Complementary therapies in long-stay
neurology in-patient settings,”Nursing Standard, vol. 13, no. 32,
pp. 32–35, 1999.
[57] P. Conrad and C. Adams, “The effects of clinical aromather-
apy for anxiety and depression in the high risk postpartum
woman—a pilot study,” Complementary Therapies in Clinical
Practice, vol. 18, no. 3, pp. 164–168, 2012.
[58] J. Lehrner, G. Marwinski, S. Lehr, P. Johren, and L. Deecke,
“Ambient odors of orange and lavender reduce anxiety and
improve mood in a dental office,” Physiology and Behavior, vol.
86, no. 1-2, pp. 92–95, 2005.
[59] M. Kritsidima, T. Newton, and K. Asimakopoulou, “The effects
of lavender scent on dental patient anxiety levels: a cluster
randomised-controlled trial,” Community Dentistry and Oral
Epidemiology, vol. 38, no. 1, pp. 83–87, 2010.
[60] R. Braden, S. Reichow, andM.A.Halm, “Theuse of the essential
oil Lavandin to reduce preoperative anxiety in surgical patients,”
Journal of Perianesthesia Nursing, vol. 24, no. 6, pp. 348–355,
2009.
[61] B. F. Bradley, S. L. Brown, S. Chu, andR.W. Lea, “Effects of orally
administered lavender essential oil on responses to anxiety-
provoking film clips,” Human Psychopharmacology, vol. 24, no.
4, pp. 319–330, 2009.
[62] S. Akhondzadeh, L. Kashani, A. Fotouhi et al., “Comparison
of Lavandula angustifolia Mill. tincture and imipramine in
the treatment of mild to moderate depression: a double-blind,
randomized trial,” Progress in Neuro-Psychopharmacology and
Biological Psychiatry, vol. 27, no. 1, pp. 123–127, 2003.
[63] X. Duan,M. Tashiro, D.Wu et al., “Autonomic nervous function
and localization of cerebral activity during lavender aromatic
immersion,” Technology and Health Care, vol. 15, no. 2, pp. 69–
78, 2007.
[64] J. Wang, P. J. Eslinger, M. B. Smith, and Q. X. Yang, “Functional
magnetic resonance imaging study of human olfaction and
normal aging,” Journals of Gerontology A, vol. 60, no. 4, pp. 510–
514, 2005.
[65] W. Di Nardo, S. Di Girolamo, A. Galli, G. Meduri, G. Paludetti,
and G. de Rossi, “Olfactory function evaluated by SPECT,”
American Journal of Rhinology, vol. 14, no. 1, pp. 57–61, 2000.
[66] D. M. Small, J. C. Gerber, Y. E. Mak, and T. Hummel, “Differ-
ential neural responses evoked by orthonasal versus retronasal
odorant perception in humans,” Neuron, vol. 47, no. 4, pp. 593–
605, 2005.
[67] M. A. Diego, N. A. Jones, T. Field et al., “Aromatherapy
positively affects mood, EEG patterns of alertness and math
computations,” International Journal of Neuroscience, vol. 96,
no. 3-4, pp. 217–224, 1998.
[68] G. D. Jacobs, H. Benson, and R. Friedman, “Topographic EEG
mapping of the relaxation response,” Biofeedback and Self-
Regulation, vol. 21, no. 2, pp. 121–129, 1996.
[69] W. Sayorwan, V. Siripornpanich, T. Piriyapunyaporn, T. Hon-
gratanaworakit, N. Kotchabhakdi, and N. Ruangrungsi, “The
effects of lavender oil inhalation on emotional states, autonomic
nervous system, and brain electrical activity,” Journal of the
Medical Association of Thailand, vol. 95, pp. 598–606, 2012.
[70] R.Masago, T.Matsuda, Y. Kikuchi et al., “Effects of inhalation of
essential oils on EEG activity and sensory evaluation,” Journal of
Physiological Anthropology and Applied Human Science, vol. 19,
no. 1, pp. 35–42, 2000.
[71] C. Holmes, V. Hopkins, C. Hensford, V. MacLaughlin, D.
Wilkinson, and H. Rosenvinge, “Lavender oil as a treatment
for agitated behaviour in severe dementia: a placebo controlled
study,” International Journal of Geriatric Psychiatry, vol. 17, no.
4, pp. 305–308, 2002.
[72] D. A. Moscovitch, D. L. Santesso, V. Miskovic et al., “Frontal
EEG asymmetry and symptom response to cognitive behavioral
therapy in patients with social anxiety disorder,” Biological
Psychology, vol. 87, no. 3, pp. 379–385, 2011.
[73] C. Sanders, M. Diego, M. Fernandez, T. Field, M. Hernandez-
Reif, and A. Roca, “EEG asymmetry responses to lavender and
rosemary aromas in adults and infants,” International Journal of
Neuroscience, vol. 112, no. 11, pp. 1305–1320, 2002.
[74] K. Hirokawa, T. Nishimoto, and T. Taniguchi, “Effects of
lavender aroma on sleep quality in healthy Japanese students,”
Perceptual & Motor Skills, vol. 114, no. 1, pp. 111–122, 2012.
[75] M. Moeini, M. Khadibi, R. Bekhradi et al., “Effect of aro-
matherapy on the quality of sleep in ischemic heart disease
Evidence-Based Complementary and Alternative Medicine 9
patients hospitalized in intensive care units of heart hospitals
of the Isfahan University of Medical Sciences,” Iranian Journal
of Nursing and Midwifery Research, vol. 15, no. 4, pp. 234–239,
2010.
[76] L. W. Chien, S. L. Cheng, and C. F. Liu, “The effect of
lavender aromatherapy on autonomic nervous system inmidlife
women with insomnia,” Evidence-Based Complementary and
Alternative Medicine, vol. 2012, Article ID 740813, 8 pages, 2012.
[77] G. T. Lewith, A. D. Godfrey, and P. Prescott, “A single-blinded,
randomized pilot study evaluating the aroma of Lavandula
augustifolia as a treatment for mild insomnia,” Journal of
Alternative and Complementary Medicine, vol. 11, no. 4, pp. 631–
637, 2005.
[78] C. Graham, “Complementary therapies: in the scent of a good
night’s sleep,” Nursing Standard, vol. 9, article 21, 1995.
[79] M. Hardy, M. D. Kirk-Smith, and D. D. Stretch, “Replacement
of drug treatment for insomnia by ambient odour,” Lancet, vol.
346, no. 8976, p. 701, 1995.
[80] R. Hudson, “The value of lavender for rest and activity in the
elderly patient,” Complementary Therapies in Medicine, vol. 4,
no. 1, pp. 52–57, 1996.
[81] T. I. Williams, “Evaluating effects of aromatherapy massage on
sleep in children with autism: a pilot study,” Evidence-Based
Complementary and Alternative Medicine, vol. 3, no. 3, pp. 373–
377, 2006.
[82] M. Ching, “Contemporary therapy: aromatherapy in the man-
agement of acute pain?” Contemporary Nurse, vol. 8, no. 4, pp.
146–151, 1999.
[83] A. Woolfson and D. Hewitt, “Intensive aromacare,” Interna-
tional Journal of Aromatherapy, vol. 4, no. 2, pp. 12–13, 1992.
[84] D. T. Altaei, “Topical lavender oil for the treatment of recurrent
aphthous ulceration,” American Journal of Dentistry, vol. 25, no.
1, pp. 39–43, 2012.
[85] S. Kim, H. J. Kim, J. S. Yeo et al., “The effect of lavender
oil on stress, bispectral index values, and needle insertion
pain in volunteers,” Journal of Alternative and Complementary
Medicine, vol. 17, no. 9, pp. 823–826, 2011.
[86] M. C. Ou, T. F. Hsu, A. C. Lai et al., “Pain relief assessment by
aromatic essential oil massage on outpatients with primary dys-
menorrhea: a randomized, double-blind clinical trial,” Journal
of Obstetrics and Gynaecology Research, vol. 38, no. 5, pp. 817–
822, 2012.
[87] N. Hadi and A. A. Hanid, “Lavender essence for post-cesarean
pain,” Pakistan Journal of Biological Sciences, vol. 14, no. 11, pp.
664–667, 2011.
[88] K. Vakilian, M. Atarha, R. Bekhradi, and R. Chaman, “Healing
advantages of lavender essential oil during episiotomy recovery:
a clinical trial,” Complementary Therapies in Clinical Practice,
vol. 17, no. 1, pp. 50–53, 2011.
[89] F. Sheikhan, F. Jahdi, E. M. Khoei et al., “Episiotomy pain relief:
use of Lavender oil essence in primiparous Iranian women,”
Complementary Therapies in Clinical Practice, vol. 18, no. 1, pp.
66–70, 2012.
[90] A. Dale and S. Cornwell, “The role of lavender oil in relieving
perineal discomfort following childbirth: a blind randomized
clinical trial,” Journal of Advanced Nursing, vol. 19, no. 1, pp. 89–
96, 1994.
[91] J. T. Kim, M.Wajda, G. Cuff et al., “Evaluation of aromatherapy
in treating postoperative pain: pilot study,” Pain Practice, vol. 6,
no. 4, pp. 273–277, 2006.
[92] J. T. Kim, C. J. Ren, G. A. Fielding et al., “Treatment with
lavender aromatherapy in the post-anesthesia care unit reduces
opioid requirements of morbidly obese patients undergoing
laparoscopic adjustable gastric banding,” Obesity Surgery, vol.
17, no. 7, pp. 920–925, 2007.
[93] L. D. Grunebaum, J. Murdock, M. P. Castanedo-Tardan, and L.
S. Baumann, “Effects of lavender olfactory input on cosmetic
procedures,” Journal of Cosmetic Dermatology, vol. 10, no. 2, pp.
89–93, 2011.
[94] Y. B. Yip and S. H. M. Tse, “The effectiveness of relaxation
acupoint stimulation and acupressure with aromatic lavender
essential oil for non-specific low back pain in Hong Kong:
a randomised controlled trial,” Complementary Therapies in
Medicine, vol. 12, no. 1, pp. 28–37, 2004.
[95] Y. B. Yip and S. H. M. Tse, “An experimental study on the
effectiveness of acupressure with aromatic lavender essential
oil for sub-acute, non-specific neck pain in Hong Kong,”
Complementary Therapies in Clinical Practice, vol. 12, no. 1, pp.
18–26, 2006.
[96] M. H. Hur, Y. S. Yang, and M. S. Lee, “Aromatherapy massage
affects menopausal symptoms in Korean climacteric women: a
pilot-controlled clinical trial,” Evidence-Based Complementary
and Alternative Medicine, vol. 5, no. 3, pp. 325–328, 2008.
[97] M. P. Pase, J. Kean, J. Sarris, C. Neale, A. B. Scholey, and C.
Stough, “The cognitive-enhancing effects of Bacopa monnieri:
a systematic review of randomized, controlled human clinical
trials,” Journal of Alternative Complementary Medicine, vol. 18,
no. 7, pp. 647–652, 2012.
[98] M. Moss, J. Cook, K. Wesnes, and P. Duckett, “Aromas of
rosemary and lavender essential oils differentially affect cog-
nition and mood in healthy adults,” International Journal of
Neuroscience, vol. 113, no. 1, pp. 15–38, 2003.
[99] P. Tysoe, “The effect on staff of essential oil burners in extended
care settings,” International Journal of Nursing Practice, vol. 6,
no. 2, pp. 110–112, 2000.
[100] D. Jimbo, Y. Kimura, M. Taniguchi, M. Inoue, and K. Urakami,
“Effect of aromatherapy on patients with Alzheimer’s disease,”
Psychogeriatrics, vol. 9, no. 4, pp. 173–179, 2009.
[101] J. Degel and E. P. Ko¨ster, “Odors: implicit memory and perfor-
mance effects,” Chemical Senses, vol. 24, no. 3, pp. 317–325, 1999.
[102] H. W. Ludvigson and T. R. Rottman, “Effects of ambient odors
of lavender and cloves on cognition, memory, affect andmood,”
Chemical Senses, vol. 14, no. 4, pp. 525–536, 1989.
[103] B. Uehleke, S. Schaper, A. Dienel, S. Schlaefke, and R. Stange,
“Phase II trial on the effects of Silexan in patients with
neurasthenia, post-traumatic stress disorder or somatization
disorder,” Phytomedicine, vol. 19, no. 8-9, pp. 665–671, 2012.
[104] D. V. Henley, N. Lipson, K. S. Korach, and C. A. Bloch,
“Prepubertal gynecomastia linked to lavender and tea tree oils,”
New England Journal of Medicine, vol. 356, no. 5, pp. 479–485,
2007.
[105] F. M. Branda˜o, “Occupational allergy to lavender oil,” Contact
Dermatitis, vol. 15, no. 4, pp. 249–250, 1986.
[106] M. Sugiura, R. Hayakawa, Y. Kato, K. Sugiura, and R.
Hashimoto, “Results of patch testing with lavender oil in Japan,”
Contact Dermatitis, vol. 43, no. 3, pp. 157–160, 2000.
[107] H. Woelk and S. Schla¨fke, “A multi-center, double-blind,
randomised study of the Lavender oil preparation Silexan in
comparison to Lorazepam for generalized anxiety disorder,”
Phytomedicine, vol. 17, no. 2, pp. 94–99, 2010.
10 Evidence-Based Complementary and Alternative Medicine
[108] E. Ernst, “Herbal medicinal products during pregnancy: are
they safe?” British Journal of Gynecology, vol. 109, no. 3, pp. 227–
235, 2002.
[109] R. Perry, R. Terry, L. K. Watson, and E. Ernst, “Is lavender an
anxiolytic drug? A systematic review of randomised clinical
trials,” Phytomedicine, vol. 19, pp. 825–835, 2012.
[110] A. V. Dwyer, D. L. Whitten, and J. A. Hawrelak, “Herbal
medicines, other than St. John’s Wort, in the treatment of
depression: a systematic review,” Alternative Medicine Review,
vol. 16, no. 1, pp. 40–49, 2011.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
International Journal of
Endocrinology
Hindawi Publishing Corporation
http://www.hindawi.com
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
BioMed Research 
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
PPAR
Resea rch
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Parkinson’s Disease
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
